Impact of Frailty and Prevalent Fractures on the Long-term Prognosis of Patients with Cirrhosis: a Retrospective Study

Overview

Journal Sci Rep

Specialty Science

Date 2025 Jan 2

PMID 39747234

Authors

Takashi Niwa

Chisato Saeki

Mitsuru Saito

Tsunekazu Oikawa

Hiroshi Kamioka

Tomoya Kanai

Kaoru Ueda

Masanori Nakano

Yuichi Torisu

Masayuki Saruta

Akihito Tsubota

Affiliations

Soon will be listed here.

Abstract

Frailty and fractures are closely associated with adverse clinical outcomes. This retrospective study investigated the prognostic impact of frailty, prevalent fractures, and the coexistence of both in patients with cirrhosis. Frailty was defined according to the Fried frailty phenotype criteria: weight loss, weakness, exhaustion, slowness, and low physical activity. Prevalent fractures were assessed using questionnaires and lateral thoracolumbar spine radiographs. Cumulative survival rates were compared between the frailty and non-frailty groups, fracture and non-fracture groups, and all four groups stratified by the presence or absence of frailty and/or prevalent fractures. Among 189 patients with cirrhosis, 70 (37.0%) and 74 (39.2%) had frailty and prevalent fractures, respectively. The median observation period was 64.4 (38.6-71.7) months, during which 50 (26.5%) liver disease-related deaths occurred. Multivariate analysis identified frailty and prevalent fractures as significant independent prognostic factors in the overall cohort (p < 0.001 and p = 0.003, respectively). The cumulative survival rates were lower in the frailty or fracture groups than in the non-frailty or non-fracture groups, respectively, in the overall cohort and in patients with compensated and decompensated cirrhosis. Patients with both frailty and prevalent fractures showed the lowest cumulative survival rates, whereas those without these comorbidities showed the highest cumulative survival rates among the four stratified groups. Frailty and prevalent fractures were independently associated with mortality in patients with cirrhosis. Additionally, the coexistence of both comorbidities worsened the prognosis.

References

Ensrud K, Ewing S, Taylor B, Fink H, Stone K, Cauley J . Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci. 2007; 62(7):744-51. DOI: 10.1093/gerona/62.7.744. View

Kim H, Park S, Park S, Park J, Chang B, Lee C . Prevalence of Frailty in Patients with Osteoporotic Vertebral Compression Fracture and Its Association with Numbers of Fractures. Yonsei Med J. 2018; 59(2):317-324. PMC: 5823836. DOI: 10.3349/ymj.2018.59.2.317. View

Middleton R, Poveda J, Orfila Pernas F, Martinez Laguna D, Perez A, Nogues X . Mortality, Falls, and Fracture Risk Are Positively Associated With Frailty: A SIDIAP Cohort Study of 890 000 Patients. J Gerontol A Biol Sci Med Sci. 2021; 77(1):148-154. PMC: 8751782. DOI: 10.1093/gerona/glab102. View

. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018; 69(2):406-460. DOI: 10.1016/j.jhep.2018.03.024. View

Liang J, Meng W, Yang J, Li S, Zhong M, Hou X . The association between liver cirrhosis and fracture risk: A systematic review and meta-analysis. Clin Endocrinol (Oxf). 2018; 89(4):408-413. DOI: 10.1111/cen.13762. View

Schonau J, Wester A, Hagstrom H, Schattenberg J . Authors reply: Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis. J Intern Med. 2023; 294(4):537-538. DOI: 10.1111/joim.13679. View

Shiraki M, Kashiwabara S, Imai T, Tanaka S, Saito M . The association of urinary pentosidine levels with the prevalence of osteoporotic fractures in postmenopausal women. J Bone Miner Metab. 2019; 37(6):1067-1074. DOI: 10.1007/s00774-019-01017-9. View

Pugh R, Murray-Lyon I, Dawson J, Pietroni M, Williams R . Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60(8):646-9. DOI: 10.1002/bjs.1800600817. View

Fried L, Tangen C, Walston J, Newman A, Hirsch C, Gottdiener J . Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56(3):M146-56. DOI: 10.1093/gerona/56.3.m146. View

10.

Lyles K, Gold D, Shipp K, Pieper C, Martinez S, Mulhausen P . Association of osteoporotic vertebral compression fractures with impaired functional status. Am J Med. 1993; 94(6):595-601. DOI: 10.1016/0002-9343(93)90210-g. View

11.

Iida H, Sakai Y, Seki T, Watanabe T, Wakao N, Matsui H . Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture. Osteoporos Int. 2022; 33(5):1147-1154. DOI: 10.1007/s00198-021-06264-z. View

12.

Saeki C, Saito M, Kanai T, Nakano M, Oikawa T, Torisu Y . Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease. PLoS One. 2021; 16(4):e0249728. PMC: 8018620. DOI: 10.1371/journal.pone.0249728. View

13.

Chen T, Lin C, Shih C, Huang Y, Yeh C, Wu C . Risk and adverse outcomes of fractures in patients with liver cirrhosis: two nationwide retrospective cohort studies. BMJ Open. 2017; 7(10):e017342. PMC: 5640047. DOI: 10.1136/bmjopen-2017-017342. View

14.

Kojima G . Frailty as a predictor of fractures among community-dwelling older people: A systematic review and meta-analysis. Bone. 2016; 90:116-22. DOI: 10.1016/j.bone.2016.06.009. View

15.

. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994; 843:1-129. View

16.

Lai J, Rahimi R, Verna E, Kappus M, Dunn M, McAdams-DeMarco M . Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. Gastroenterology. 2019; 156(6):1675-1682. PMC: 6475483. DOI: 10.1053/j.gastro.2019.01.028. View

17.

Saeki C, Takano K, Oikawa T, Aoki Y, Kanai T, Takakura K . Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis. BMC Musculoskelet Disord. 2019; 20(1):615. PMC: 6933666. DOI: 10.1186/s12891-019-2983-4. View

18.

Kok B, Abraldes J . Child-Pugh Classification: Time to Abandon?. Semin Liver Dis. 2019; 39(1):96-103. DOI: 10.1055/s-0038-1676805. View

19.

Sharma S, Khalili K, Nguyen G . Non-invasive diagnosis of advanced fibrosis and cirrhosis. World J Gastroenterol. 2014; 20(45):16820-30. PMC: 4258552. DOI: 10.3748/wjg.v20.i45.16820. View

20.

Lupoli R, Di Minno A, Spadarella G, Ambrosino P, Panico A, Tarantino L . The risk of osteoporosis in patients with liver cirrhosis: a meta-analysis of literature studies. Clin Endocrinol (Oxf). 2015; 84(1):30-8. DOI: 10.1111/cen.12780. View